Wolfe Research Reiterated a Peer Perform Rating on Centene Corporation (CNC)

Centene Corporation (NYSE:CNC) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On July 2, Wolfe Research analyst Justin Lake reiterated a Peer Perform rating on Centene Corporation (NYSE:CNC) without disclosing any price target.

The analyst noted that the company withdrew its 2025 earnings guidance, which was driven by significant pressure in Centene Corporation’s (NYSE:CNC) health insurance business. Notably, due to unexpected and elevated cost trends in Medicaid and challenges in the Health Insurance Marketplace risk adjustment transfers.

Wolfe Research lowered its EPS estimates for 2025 and 2026, expecting that the pressure from Medicaid, which is a much larger part of Centene Corporation (NYSE:CNC)’s business, would not be offset by Medicare or SG&A improvements. Due to the uncertainty surrounding 2026, the firm stated it would not be a buyer on the stock’s weakness following the guidance withdrawal.

Centene Corporation (NYSE:CNC) is a healthcare company that provides integrated services to government-sponsored and commercial healthcare programs.

While we acknowledge the potential of CNC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.